Valuation: Zoetis Inc.

Market Cap 31.1B 27.35B 25.41B 23.37B 43.83B 3,012B 44.62B 304B 119B 1,469B 117B 114B 5,097B P/E 2026 *
11.6x
P/E 2027 * 10.6x
Enterprise Value 37.83B 33.27B 30.91B 28.43B 53.31B 3,663B 54.26B 370B 144B 1,787B 142B 139B 6,199B EV / Sales 2026 *
3.88x
EV / Sales 2027 * 3.64x
Free-Float
83.58%
Yield 2026 *
2.9%
Yield 2027 * 3.12%
1 day-0.40%
1 week-2.79%
Current month+4.20%
1 month-2.50%
3 months-34.23%
6 months-38.04%
Current year-38.97%
1 week 64.86
Extreme 64.86
67.72
1 month 62.7
Extreme 62.7
70.02
Current year 62.7
Extreme 62.7
114.98
1 year 62.7
Extreme 62.7
137.14
3 years 62.7
Extreme 62.7
185
5 years 62.7
Extreme 62.7
221
10 years 62.7
Extreme 62.7
221
Manager TitleAgeSince
Chief Executive Officer 54 31/12/2019
Director of Finance/CFO 54 31/05/2021
Chief Tech/Sci/R&D Officer 49 31/12/2025
Director TitleAgeSince
Director/Board Member 68 30/06/2012
Director/Board Member 68 31/12/2012
Chairman 73 25/06/2013
Change 5-day change 1-year change 3-year change Capi.($)
+0.49%-2.79% - - 31.1B
-1.87%-3.41%+66.88%+108.01% 12.66B
+1.84%+5.45%-19.46%+1.84% 3.72B
-4.43%+2.45%-7.60%+24.35% 3.35B
+2.30%-5.32%+32.72%+12.78% 1.82B
-1.62%+2.76%-10.80%+23.71% 1.86B
-0.09%-1.77%+13.83%+124.87% 1.37B
+1.01%-1.29%-24.79%-13.46% 1.07B
+0.78%-0.77%-17.26%-47.86% 968M
-1.26%-2.61%-7.57%-21.68% 951M
Average -0.36%+2.16%+2.88%+23.62% 3.08B
Weighted average by Cap. -0.73%+1.92%+27.27%+58.10%

Financials

2026 *2027 *
Net sales 9.75B 8.58B 7.97B 7.33B 13.74B 945B 13.99B 95.29B 37.17B 461B 36.62B 35.82B 1,598B 10.15B 8.93B 8.29B 7.63B 14.3B 983B 14.56B 99.16B 38.68B 479B 38.1B 37.28B 1,663B
Net income 2.7B 2.37B 2.21B 2.03B 3.81B 261B 3.87B 26.38B 10.29B 128B 10.14B 9.92B 442B 2.93B 2.58B 2.4B 2.21B 4.14B 284B 4.21B 28.67B 11.18B 139B 11.02B 10.78B 481B
Net Debt 6.72B 5.91B 5.49B 5.05B 9.48B 651B 9.65B 65.7B 25.63B 318B 25.24B 24.7B 1,102B 5.83B 5.12B 4.76B 4.38B 8.21B 564B 8.36B 56.93B 22.21B 275B 21.88B 21.4B 955B
Logo Zoetis Inc.
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - companion animal (67.8%): cats and dogs (95.5% of net sales) and horses (4.5%); - livestock (31.3%): cattle (52.8% of sales), poultry (18.2%), swine (17.8%), fish (8.4%) and other (2.8%); - other (0.9%). Net sales break down by family of products into parasiticides (23.3%), vaccines (19.7%), dermatological products (17.9%), anti-infectives (11.9%), pain relievers (9.2%), diagnostic products (4.2%), medicated feed additives (3.2%) and other (10.6%). At the end of 2024, the group has 22 production sites worldwide. The United States accounts for 54.8% of net sales.
Employees
14,500
Date Price Change Volume
23/07/26 65.48 +0.49% 1,048
22/07/26 €65.16 -1.45% 1,259
21/07/26 €66.12 -0.48% 722
20/07/26 €66.44 -1.16% 1,719
17/07/26 €67.22 -0.21% 350
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
74.19USD
Average target price
113.82USD
Spread / Average Target
+53.42%

Quarterly revenue - Rate of surprise